| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.3M | +134.6% |
| R&D Expense | $50.4M | +19.0% |
| SG&A Expense | $30.8M | +6.5% |
| Operating Income | -$258.4M | +19.0% |
| Pre-tax Income | -$282.7M | +16.3% |
| Income Tax | $29K | +825.0% |
| Net Income | -$251.4M | +6.1% |
| EPS (Basic) | -$10.83 | +58.3% |
| EPS (Diluted) | -$10.83 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.4M | -55.9% |
| Accounts Receivable | $1.0M | +96.4% |
| Current Assets | $16.9M | -51.9% |
| Total Assets | $350.1M | -35.7% |
| Current Liabilities | $19.9M | -6.8% |
| Long-term Debt | $662K | -51.6% |
| Total Liabilities | $252.2M | +22.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.0M | -25.6% |
| Capital Expenditures | $808K | -81.3% |
| Investing Cash Flow | -$808K | -101.5% |
| Financing Cash Flow | $40.6M | +99.8% |
| Free Cash Flow | -$58.9M | -16.5% |
| +58.3% |
| Stockholders' Equity |
| $92.2M |
| -68.6% |